2016 American Transplant Congress

June 11-15, 2016 in Boston, MA

View by Title View Sessions

View by Date

Monday, June 13, 2016

4:42pm-4:54pm: How Did the New Kidney and Pancreas Allocation Systems Effect Pancreas Utilization in the First Six-Months?

R. Carrico,¹ J. Fridell,² J. Odorico,³ Z. Stewart.⁴

Concurrent Session: Clinical Pancreas Transplantation 1 • Room 309

4:42pm-4:54pm: Inclusion of Human Tissue Factor Pathway Inhibitor or Thrombomodulin Transgenes Attenuates Critical Consumptive Thrombocytopenia in Cardiac Xenotransplantation.

J. Chan,¹ A. Singh,¹ P. Corcoran,¹ M. Thomas III,² B. Lewis,² D. Ayares,³ K. Horvath,¹ M. Mohiuddin.¹

Concurrent Session: Xenotransplantation: Animal Models • Room 102

4:42pm-4:54pm: Long-Term Assessment of the Safety and Efficacy of IVIG and Rituximab-Based Desensitization (DES).

J. Choi, J. Kahwaji, A. Vo, S. Louie, A. Kang, A. Peng, R. Villicana, D. Puliyanda, I. Kim, S. Jordan.

Concurrent Session: Kidney: Desensitization • Room 304

4:42pm-4:54pm: Long-Term Outcomes After Pediatric Liver Transplantation for Malignant Liver Tumors: Effects of Era and Age.

R. Patel,¹ I. Feurer,¹ S. Karp,¹ L. Gillis,¹ H. Katzenstein,¹ H. Lovvorn III,¹ J. Pietsch,¹ D. Chung, G. Tiao,² D. Hanto.¹

Concurrent Session: Pediatric Liver Transplant • Room 206

4:42pm-4:54pm: Non-Invasive Biomarkers for Graft Quality and Outcome Post-Liver Transplantation.

R. Gehrau, V. Mas, S. Bontha, D. Maluf.

Concurrent Session: Liver Transplantation Peri-Operative Considerations • Room 311

4:42pm-4:54pm: Pharmacist Impact on Medication Errors in a Chronic Kidney Transplant Clinic.

K. Covert,¹ C. Mardis,¹ J. Fleming,¹ A. Mardis,¹ H. Meadows,¹ N. Pilch,¹ P. Mohan,² M. Posadas,² M. Salazar,² T. Srinivas,² G. Mour,² D. Taber.¹

Concurrent Session: Medication Errors, Variability and Adherence • Room 302

4:42pm-4:54pm: Post-Transplant Monitoring of Donor-Specific Anti-HLA Antibodies and Their Characteristics Improves Risk Stratification of Kidney Allograft Loss.

D. Viglietti,¹ A. Loupy,² C. Bentlejewski,³ C. Legendre,² D. Glotz,¹ A. Zeevi,³ C. Lefaucheur.¹

Concurrent Session: Kidney Transplant Recipient: Long Term Outcomes Session I • Veterans Auditorium

4:42pm-4:54pm: Share35 Liver Allocation Is Associated with Increased Early Graft Failure Rate.

T. Wong,¹ N. Koizumi,² J. Ortiz.³

Concurrent Session: Late Breaking • Room 210

4:42pm-4:54pm: Significant Association of Vitamin-D Receptor (VDR) Gene Polymorphism and Incidence of De Novo DSA in Renal Transplantation.

L. Das, K. Ide, Y. Tanaka, N. Tanimine, S. Verma, H. Ohdan.

Concurrent Session: Antibody Mediated Rejection in Kidney Transplantation: De Novo DSA • Ballroom B

4:42pm-4:54pm: The Optimal Time Point for Steroid Withdrawal After Kidney Transplantation Is One Year After Engraftment.

M. Haller,¹ M. Kammer,^1,2 A. Kainz,² G. Heinze,¹ R. Oberbauer.^1,2

Concurrent Session: Belatacept and Steroid Withdrawal in Kidney Transplantation • Ballroom A